Mattel Children's Hospital, University of California, Los Angeles, CA 90095, USA.
Biomed Res Int. 2013;2013:137985. doi: 10.1155/2013/137985. Epub 2013 Sep 8.
Transcatheter treatment of children with congenital heart disease such as coarctation of the aorta and pulmonary artery stenosis currently involves the use of metal stents. While these provide good short term results, there are long term complications with their use. Children outgrow metal stents, obligating them to future transcatheter dilations and eventual surgical removal. A bioabsorbable stent, or a stent that goes away with time, would solve this problem. Bioabsorbable stents are being developed for use in coronary arteries, however these are too small for use in pediatric congenital heart disease. A bioabsorbable stent for use in pediatric congenital heart disease needs to be low profile, expandable to a diameter 8 mm, provide sufficient radial strength, and absorb quickly enough to allow vessel growth. Development of absorbable coronary stents has led to a great understanding of the available production techniques and materials such as bioabsorbable polymers and biocorrodable metals. Children with congenital heart disease will hopefully soon benefit from the current generation of bioabsorbable and biocorrodable materials and devices.
经导管治疗儿童先天性心脏病,如主动脉缩窄和肺动脉狭窄,目前涉及使用金属支架。虽然这些支架在短期内效果良好,但长期使用会产生并发症。儿童会长出金属支架,需要未来进行经导管扩张和最终的手术切除。可生物吸收的支架,即随时间消失的支架,将解决这个问题。可生物吸收的支架正在开发用于冠状动脉,但这些支架对于儿科先天性心脏病来说太小了。用于儿科先天性心脏病的可生物吸收支架需要具有低轮廓、可扩展至 8mm 直径、提供足够的径向强度,并能快速吸收以允许血管生长。可吸收冠状动脉支架的开发使人们对可用的生产技术和材料有了更深入的了解,如可生物吸收聚合物和可生物腐蚀性金属。患有先天性心脏病的儿童有望很快受益于当前一代的可生物吸收和可生物腐蚀性材料和装置。